157 related articles for article (PubMed ID: 7251471)
1. Physico-chemical properties of new acyl derivatives of tylosin produced by microbial transformation.
Okamoto R; Fukumoto T; Nomura H; Kiyoshima K; Nakamura K; Takamatsu A; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1300-8. PubMed ID: 7251471
[TBL] [Abstract][Full Text] [Related]
2. Microbial transformation of antibiotics II. Additional transformation products of maridomycin III.
Shibata M; Uyeda M; Mori S
J Antibiot (Tokyo); 1976 Aug; 29(8):824-8. PubMed ID: 993121
[TBL] [Abstract][Full Text] [Related]
3. Binding of 3-O-acetyl-4"-O-isovaleryltylosin to ribosomes from a macrolide-resistant strain of Staphylococcus aureus.
Tsuchiya M; Sawa T; Takeuchi T; Umezawa H; Okamoto R
J Antibiot (Tokyo); 1982 Jun; 35(6):673-9. PubMed ID: 7118723
[TBL] [Abstract][Full Text] [Related]
4. New tylosin analogs produced by mutants of Streptomyces fradiae.
Kiyoshima K; Takada K; Yamamoto M; Kubo K; Okamoto R; Fukagawa Y; Ishikura T; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1987 Aug; 40(8):1123-30. PubMed ID: 3680024
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of 3-acetyl-4"-isovaleryltylosin against multiple-drug resistant strains of Staphylococcus aureus.
Tsuchiya M; Suzukake K; Hori M; Sawa T; Takeuchi T; Umezawa H; Okamoto R; Nomura H; Tsunekawa H; Inui T
J Antibiot (Tokyo); 1981 Mar; 34(3):305-12. PubMed ID: 7275812
[TBL] [Abstract][Full Text] [Related]
6. The microbial transformation of tylosin by the spiramycin-producing strain, Streptomyces ambofaciens KA-1028.
Omura S; Kitao C; Sadakane N
J Antibiot (Tokyo); 1980 Aug; 33(8):911-2. PubMed ID: 7429995
[No Abstract] [Full Text] [Related]
7. Microbial transformation of antibiotics. III. Reacylation of 4"-depropionyl maridomycin III into maridomycin V (maridomycin K) by Streptomyces sp. strain no. K-342.
Uyeda M; Mori S; Morita M; Ogata T; Mori M; Shibata M
J Antibiot (Tokyo); 1977 Dec; 30(12):1130-1. PubMed ID: 599088
[No Abstract] [Full Text] [Related]
8. [Identification of the antibiotic formed by a Str. canulus 106/78 culture with antibiotic CC-1065].
Frolova VI; Kuzovkov AD; Chernyshev AI; Taĭg MM; Ivanitskaia LP
Antibiotiki; 1982; 27(7):483-7. PubMed ID: 7137972
[TBL] [Abstract][Full Text] [Related]
9. Microbial transformation of maridomycin III by Serratia marcescens.
Uyeda M; Kubota K; Miyamura S; Shibata M
J Antibiot (Tokyo); 1983 Dec; 36(12):1722-8. PubMed ID: 6363373
[TBL] [Abstract][Full Text] [Related]
10. Biological properties of new acyl derivatives of tylosin.
Okamoto R; Tsuchiya M; Nomura H; Iguchi H; Kiyoshima K; Hori S; Inui T; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1980 Nov; 33(11):1309-15. PubMed ID: 7251472
[TBL] [Abstract][Full Text] [Related]
11. [Isolation and study of a new antitumor antibiotic produced by a Str. coerulescens 1072 culture].
Frolova VI; Kuzovkov AD; Rozynov BV; Sheichenko VI; Taĭg MM
Antibiotiki; 1982 Aug; 27(8):563-9. PubMed ID: 7125613
[No Abstract] [Full Text] [Related]
12. [Fragmentation characteristics of the polyether antibiotic complex isolated from Streptomyces hygroscopicus strains IM-110-81 and IM-111-81 (DIKLS) in mass spectrometry].
Rachev R; Ivanova V; Sakhanekova M; Schlegel R; Kleinwächter W
Acta Microbiol Bulg; 1985; 16():11-21. PubMed ID: 4036666
[No Abstract] [Full Text] [Related]
13. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy.
Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G
Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162
[TBL] [Abstract][Full Text] [Related]
14. Novel antifungal antibiotics maniwamycins A and B. I. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological properties.
Nakayama M; Takahashi Y; Itoh H; Kamiya K; Shiratsuchi M; Otani G
J Antibiot (Tokyo); 1989 Nov; 42(11):1535-40. PubMed ID: 2584134
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of 3,4''-ester derivatives of 16-membered macrolide antibiotics related to tylosin.
Kirst HA; Debono M; Willard KE; Truedell BA; Toth JE; Turner JR; Berry DR; Briggs BB; Fukuda DS; Daupert VM
J Antibiot (Tokyo); 1986 Dec; 39(12):1724-35. PubMed ID: 3818446
[TBL] [Abstract][Full Text] [Related]
16. Deltamycins, new macrolide antibiotics. III. Chemical structures.
Shimauchi Y; Kubo K; Osumi K; Okamura K; Fukagawa Y; Ishikura T; Lein J
J Antibiot (Tokyo); 1979 Sep; 32(9):878-83. PubMed ID: 511779
[TBL] [Abstract][Full Text] [Related]
17. Microbial glucosidation of 1,2,4-trihydroxy-9,10-anthraquinone (purpurin).
Steinerová N; Matĕjů J; Cudlín J; Vanĕk Z
Folia Microbiol (Praha); 1984; 29(6):433-40. PubMed ID: 6441760
[TBL] [Abstract][Full Text] [Related]
18. Genetics of Streptomyces fradiae and tylosin biosynthesis.
Baltz RH; Seno ET
Annu Rev Microbiol; 1988; 42():547-74. PubMed ID: 3060001
[No Abstract] [Full Text] [Related]
19. Biosynthesis of tylosin: oxidations of 5-O-mycaminosylprotylonolide at C-20 and C-23 with a cell-free extract from Streptomyces fradiae.
Omura S; Tanaka H; Tsukui M
Biochem Biophys Res Commun; 1982 Jul; 107(2):554-60. PubMed ID: 7126228
[No Abstract] [Full Text] [Related]
20. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms.
Sadakane N; Tanaka Y; Omura S
J Antibiot (Tokyo); 1982 Jun; 35(6):680-7. PubMed ID: 7118724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
